MK Proteins
Ticker > Company >

MK Proteins share price

MK Proteins Ltd.

  73.71 K   163   13 NSE: MKPL SECTOR: Edible Oil

4.06
+0.11 (2.78%)
BSE: Today, 04:01 PM

Buy on Angel One

Price Summary

Today's High

₹ 4.14

Today's Low

₹ 4

52 Week High

₹ 7.8

52 Week Low

₹ 3.8

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 152.4 Cr.

Enterprise Value

₹ 190.12 Cr.

No. of Shares

37.54 Cr.

P/E

32.45

P/B

1.96

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  2.07

CASH

₹ 0.03 Cr.

DEBT

₹ 37.75 Cr.

Promoter Holding

74.82 %

EPS (TTM)

₹  0.13

Sales Growth

9.08%

ROE

12.87 %

ROCE

13.46%

Profit Growth

-25.1 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year9.08%
3 Year1.52%
5 Year6.64%

Profit Growth

1 Year-25.1%
3 Year-6.23%
5 Year35.82%

ROE%

1 Year12.87%
3 Year19.17%
5 Year26.02%

ROCE %

1 Year13.46%
3 Year17.41%
5 Year20.84%

Debt/Equity

0.5435

Price to Cash Flow

-9.45

Interest Cover Ratio

10.8378

CFO/PAT (5 Yr. Avg.)

0.114021862152892

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 74.82 0.00
Mar 2026 74.82 0.00
Dec 2025 74.82 0.00
Sep 2025 74.82 0.00
Jun 2025 74.82 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has a healthy Interest coverage ratio of 10.8378.
  • The company has a high promoter holding of 74.82%.

 Limitations

  • The company has shown a poor profit growth of -6.22882456922793% for the Past 3 years.
  • The company has shown a poor revenue growth of 1.51625846157608% for the Past 3 years.
  • Company has negative cash flow from operations of -16.127942411.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 114.95 32.43 89.56 145.94 115.16
Total Expenditure 109.44 31.39 87.19 143.44 112.65
Operating Profit 5.51 1.05 2.36 2.5 2.51
Other Income 0 0.12 0.02 0.12 0
Interest 0.7 0.06 0.3 0.79 0.52
Depreciation 0.1 0.11 0.12 0.11 0.15
Exceptional Items 0 0 0 0 0
Profit Before Tax 4.71 1 1.97 1.72 1.85
Tax 1.19 0.25 0.54 0.58 0.47
Profit After Tax 3.51 0.75 1.43 1.14 1.38
Adjusted EPS (Rs) 0.09 0.02 0.04 0.03 0.04

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 311.1 255.89 314.86 245.41 267.71
Total Expenditure 295.1 240.39 297.83 228.76 255.22
Operating Profit 16 15.5 17.03 16.65 12.49
Other Income 0.06 0.34 0.67 0.45 0.48
Interest 0.82 0.89 1.9 1.1 1.16
Depreciation 0.91 0.91 0.82 0.53 0.35
Exceptional Items 0 0 0 0 0
Profit Before Tax 14.32 14.04 14.99 15.47 11.45
Tax 3.93 3.86 4.06 4.26 3.05
Net Profit 10.39 10.18 10.93 11.21 8.4
Adjusted EPS (Rs.) 0.28 0.27 0.29 0.3 0.22

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 4.17 4.17 12.51 37.54 37.54
Total Reserves 25.17 35.43 37.35 23.54 31.93
Borrowings 4.45 2.65 2.54 0 0.83
Other N/C liabilities -0.22 -0.22 0.73 0.83 0.93
Current liabilities 33.51 43.81 52.06 35.92 60.98
Total Liabilities 67.08 85.85 105.2 97.83 132.2
Assets
Net Block 2.45 3.11 3.3 2.77 3.68
Capital WIP 0 0 0 5.9 6.66
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.42 0.42 0.89 1.36 1.33
Other N/C Assets 0 0 0 0.01 0.04
Current Assets 64.2 82.31 101.02 87.79 120.49
Total Assets 67.08 85.85 105.2 97.83 132.2
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 14.32 14.04 14.99 15.47 11.45
Adjustment 1.66 1.51 2.2 1.25 1.06
Changes in Assets & Liabilities -8.24 -20.89 -18.23 19.21 -24.44
Tax Paid -1.46 -3.94 -4.83 -3.51 -4.2
Operating Cash Flow 5.54 -10.12 -5.87 32.42 -16.13
Investing Cash Flow -0.21 -1.53 0.01 -5.88 -1.48
Financing Cash Flow -5.44 11.66 5.92 -26.51 17.55
Net Cash Flow -0.11 0.01 0.06 0.03 -0.06

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2020
Annual Report 2019

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Last Updated on:
Brief about MK Proteins
X